Home page> Press center> News>FBK Grant Thornton to audit Pharmstandard JSC

FBK Grant Thornton to audit Pharmstandard JSC

Date of publication
03.06.2016
Pharmstandard’s AGM approved FBK as the auditor of the company’s RAS statements for 2016.

According to Anastasia Ivanova, Deputy Director of General Audit Department, the audit of accounting statements of the Pharmstandard Group is one of the department’s major engagements.

She went on to add, “We have maintained business relations with Pharmstandard for a number of year and steadily expanded the scope of our collaboration, which best underpins quality of the services we provide. In 2016, we are to audit the statements of fourteen companies of the Group.”

Pharmstandard JSC is one of the leading pharmaceutical companies in development and production of pharmaceuticals. Over 120 pharmaceuticals produced by Pharmstandard are listed among “Russian vital and essential drug products”.

Recommend